The Cholesteryl Ester Transfer Protein (CETP) Gene and the Risk of Alzheimer's Disease

Overview

Journal Neurogenetics

Specialty Neurology

Date 2007 May 16

PMID 17503098

Citations 18

Authors

Alejandro Arias-Vasquez

Aaron Isaacs

Yurii S Aulchenko

Albert Hofman

Ben A Oostra

Monique Breteler

Cornelia M Van Duijn

Affiliations

Soon will be listed here.

Abstract

Like the apolipoprotein E (APOE) gene, the most common genetic determinant for Alzheimer's disease (AD), the cholesteryl ester transfer protein (CETP) is involved in lipid metabolism. We studied the I405V polymorphism of the CETP gene in relation to AD. We genotyped 544 AD cases and 5,404 controls from the Rotterdam study, using a TaqMan allelic discrimination assay. Odds ratios (ORs) for AD were estimated using logistic regression analysis. CETP VV carriers showed significantly increased high-density lipoprotein levels compared to the IV and II carriers. In the overall analysis of AD, the risk of disease for the VV carriers of the CETP polymorphism was non-significantly increased compared to II carriers OR(VV) = 1.33, 95% confidence interval (CI) 0.96-1.90 p = 0.08). In those without the APOE*4 allele, the risk of AD for VV carriers was increased 1.67-fold (95% CI 1.11-2.52, p = 0.01). The difference in the relationship between CETP and AD between APOE*4 carriers and APOE*4 non-carriers was statistically significant (p for interaction = 0.04). Our results suggest that the VV genotype of the I405V polymorphism of the CETP gene increases the risk of AD in the absence of the APOE*4 allele, probably through a cholesterol metabolism pathway in the brain.

Citing Articles

Roles of peripheral lipoproteins and cholesteryl ester transfer protein in the vascular contributions to cognitive impairment and dementia.

Poliakova T, Wellington C Mol Neurodegener. 2023; 18(1):86.

PMID: 37974180 PMC: 10652636. DOI: 10.1186/s13024-023-00671-y.

Genetic Networks of Alzheimer's Disease, Aging, and Longevity in Humans.

Balmorez T, Sakazaki A, Murakami S Int J Mol Sci. 2023; 24(6).

PMID: 36982253 PMC: 10049434. DOI: 10.3390/ijms24065178.

Defective Lysosomal Lipid Catabolism as a Common Pathogenic Mechanism for Dementia.

Lee J, Marian O, Don A Neuromolecular Med. 2021; 23(1):1-24.

PMID: 33550528 DOI: 10.1007/s12017-021-08644-4.

Risk Variants in Three Alzheimer's Disease Genes Show Association with EEG Endophenotypes.

Macedo A, Gomez C, Rebelo M, Poza J, Gomes I, Martins S J Alzheimers Dis. 2021; 80(1):209-223.

PMID: 33522999 PMC: 8075394. DOI: 10.3233/JAD-200963.

Early Life Stress and Epigenetics in Late-onset Alzheimer's Dementia: A Systematic Review.

Lemche E Curr Genomics. 2018; 19(7):522-602.

PMID: 30386171 PMC: 6194433. DOI: 10.2174/1389202919666171229145156.

References

Blankenberg S, Rupprecht H, Bickel C, Jiang X, Poirier O, Lackner K . Common genetic variation of the cholesteryl ester transfer protein gene strongly predicts future cardiovascular death in patients with coronary artery disease. J Am Coll Cardiol. 2003; 41(11):1983-9. DOI: 10.1016/s0735-1097(03)00408-x. View

Folstein M, Folstein S, McHugh P . "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3):189-98. DOI: 10.1016/0022-3956(75)90026-6. View

Jurevics H, Morell P . Cholesterol for synthesis of myelin is made locally, not imported into brain. J Neurochem. 1995; 64(2):895-901. DOI: 10.1046/j.1471-4159.1995.64020895.x. View

Mahley R, Huang Y, Weisgraber K . Putting cholesterol in its place: apoE and reverse cholesterol transport. J Clin Invest. 2006; 116(5):1226-9. PMC: 1451226. DOI: 10.1172/JCI28632. View

Yanagisawa K, Matsuzaki K . Cholesterol-dependent aggregation of amyloid beta-protein. Ann N Y Acad Sci. 2002; 977:384-6. DOI: 10.1111/j.1749-6632.2002.tb04841.x. View

Jiang X, Zhou H . Plasma lipid transfer proteins. Curr Opin Lipidol. 2006; 17(3):302-8. DOI: 10.1097/01.mol.0000226124.94757.ee. View

Wolozin B, Kellman W, Ruosseau P, CELESIA G, Siegel G . Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol. 2000; 57(10):1439-43. DOI: 10.1001/archneur.57.10.1439. View

Vermeer S, Prins N, den Heijer T, Hofman A, Koudstaal P, Breteler M . Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003; 348(13):1215-22. DOI: 10.1056/NEJMoa022066. View

Zhu H, Gopalraj R, Kelly J, Bennett D, Estus S . Lack of genetic association of cholesteryl ester transfer protein polymorphisms with late onset Alzheimers disease. Neurosci Lett. 2005; 381(1-2):36-41. DOI: 10.1016/j.neulet.2005.01.078. View

10.

Mahley R, Weisgraber K, Huang Y . Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci U S A. 2006; 103(15):5644-51. PMC: 1414631. DOI: 10.1073/pnas.0600549103. View

11.

Abad-Rodriguez J, Ledesma M, Craessaerts K, Perga S, Medina M, Delacourte A . Neuronal membrane cholesterol loss enhances amyloid peptide generation. J Cell Biol. 2004; 167(5):953-60. PMC: 2172459. DOI: 10.1083/jcb.200404149. View

12.

Michikawa M . The role of cholesterol in pathogenesis of Alzheimer's disease: dual metabolic interaction between amyloid beta-protein and cholesterol. Mol Neurobiol. 2003; 27(1):1-12. DOI: 10.1385/MN:27:1:1. View

13.

Mauch D, Nagler K, Schumacher S, Goritz C, Muller E, Otto A . CNS synaptogenesis promoted by glia-derived cholesterol. Science. 2001; 294(5545):1354-7. DOI: 10.1126/science.294.5545.1354. View

14.

Rodriguez E, Mateo I, Infante J, Llorca J, Berciano J, Combarros O . Cholesteryl ester transfer protein (CETP) polymorphism modifies the Alzheimer's disease risk associated with APOE epsilon4 allele. J Neurol. 2005; 253(2):181-5. DOI: 10.1007/s00415-005-0945-2. View

15.

Puglielli L, Tanzi R, Kovacs D . Alzheimer's disease: the cholesterol connection. Nat Neurosci. 2003; 6(4):345-51. DOI: 10.1038/nn0403-345. View

16.

Miller S, Dykes D, Polesky H . A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16(3):1215. PMC: 334765. DOI: 10.1093/nar/16.3.1215. View

17.

Fidani L, Goulas A, Crook R, Petersen R, Tangalos E, Kotsis A . An association study of the cholesteryl ester transfer protein TaqI B polymorphism with late onset Alzheimer's disease. Neurosci Lett. 2004; 357(2):152-4. DOI: 10.1016/j.neulet.2003.11.071. View

18.

Vance J, Hayashi H, Karten B . Cholesterol homeostasis in neurons and glial cells. Semin Cell Dev Biol. 2005; 16(2):193-212. DOI: 10.1016/j.semcdb.2005.01.005. View

19.

Simons M, Keller P, Dichgans J, Schulz J . Cholesterol and Alzheimer's disease: is there a link?. Neurology. 2001; 57(6):1089-93. DOI: 10.1212/wnl.57.6.1089. View

20.

Wenham P, Price W, Blandell G . Apolipoprotein E genotyping by one-stage PCR. Lancet. 1991; 337(8750):1158-9. DOI: 10.1016/0140-6736(91)92823-k. View